Borosil Scientific (NSE:BOROSCI) — Stock Price
Borosil Scientific (NSE:BOROSCI) is currently trading at Rs115.55 INR, down 0.19% today. Over the past 52 weeks, shares have ranged between Rs100.97 and Rs173.52. This page tracks Borosil Scientific's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BOROSCI stock market capitalisation.
Borosil Scientific (BOROSCI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Borosil Scientific's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Borosil Scientific Income Statement — Revenue, Profit & Earnings by Year
Borosil Scientific's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | Rs4.67 Billion | Rs4.37 Billion | Rs3.95 Billion | Rs980.43 Million | Rs1.06 Billion |
| Cost of Revenue | Rs2.66 Billion | Rs2.31 Billion | Rs2.13 Billion | Rs688.09 Million | Rs706.83 Million |
| Gross Profit | Rs2.01 Billion | Rs2.06 Billion | Rs1.81 Billion | Rs292.34 Million | Rs355.17 Million |
| Research & Development | — | — | — | — | — |
| SG&A | Rs726.16 Million | Rs433.60 Million | Rs538.98 Million | Rs64.32 Million | Rs55.13 Million |
| Total Operating Expenses | Rs1.58 Billion | Rs1.71 Billion | Rs3.64 Billion | Rs955.10 Million | Rs950.56 Million |
| Operating Income | Rs429.55 Million | Rs346.63 Million | Rs303.81 Million | Rs25.32 Million | Rs111.43 Million |
| EBITDA | Rs632.11 Million | Rs604.11 Million | — | — | — |
| EBIT | Rs439.73 Million | Rs419.37 Million | — | — | — |
| Interest Expense | Rs11.28 Million | Rs15.46 Million | Rs27.02 Million | Rs3.28 Million | Rs3.12 Million |
| Income Before Tax | Rs428.45 Million | Rs403.91 Million | Rs315.51 Million | Rs29.74 Million | Rs113.20 Million |
| Income Tax Expense | Rs82.63 Million | Rs136.68 Million | — | — | — |
| Net Income | Rs346.14 Million | Rs268.04 Million | Rs235.59 Million | Rs20.64 Million | Rs85.67 Million |
Borosil Scientific Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Borosil Scientific's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | Rs5.49 Billion | Rs5.09 Billion | Rs4.93 Billion | Rs1.60 Billion | Rs1.12 Billion |
| Total Current Assets | Rs3.35 Billion | Rs3.10 Billion | Rs2.91 Billion | Rs740.73 Million | Rs469.26 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | Rs1.22 Billion | Rs1.05 Billion | Rs31.90 Million | Rs324.03 Million | Rs91.31 Million |
| Net Receivables | Rs762.73 Million | Rs725.15 Million | Rs614.80 Million | Rs118.61 Million | Rs149.04 Million |
| Inventory | Rs1.03 Billion | Rs965.34 Million | Rs968.62 Million | Rs244.63 Million | Rs185.17 Million |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | Rs621.94 Million | Rs621.94 Million | Rs621.94 Million | — | — |
| Total Liabilities | Rs1.08 Billion | Rs1.04 Billion | Rs1.17 Billion | Rs663.92 Million | Rs208.91 Million |
| Total Current Liabilities | Rs927.81 Million | Rs871.27 Million | Rs999.93 Million | Rs252.64 Million | Rs182.38 Million |
| Long-term Debt | Rs7.67 Million | Rs17.42 Million | Rs44.95 Million | Rs383.06 Million | Rs0.00 |
| Net Debt | Rs-51.16 Million | Rs11.15 Million | Rs44.51 Million | Rs455.67 Million | — |
| Total Stockholder Equity | Rs4.41 Billion | Rs4.04 Billion | Rs3.76 Billion | Rs936.34 Million | Rs915.05 Million |
| Retained Earnings | Rs4.66 Billion | Rs4.31 Billion | Rs4.04 Billion | Rs13.34 Million | Rs-7.30 Million |
Borosil Scientific Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Borosil Scientific generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs424.61 Million | Rs1.20 Billion | Rs300.01 Million | Rs-14.26 Million | Rs92.19 Million |
| Capital Expenditures | Rs284.52 Million | Rs141.64 Million | Rs128.74 Million | Rs209.63 Million | Rs131.62 Million |
| Free Cash Flow | Rs140.08 Million | Rs1.06 Billion | Rs171.27 Million | Rs-223.90 Million | Rs-39.44 Million |
| Investing Cash Flow | Rs-375.50 Million | Rs-1.15 Billion | — | — | — |
| Financing Cash Flow | Rs-50.56 Million | Rs-34.01 Million | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | Rs21.68 Million | Rs5.08 Million | Rs4.86 Million | Rs1.31 Million | Rs1.27 Million |
| Depreciation | Rs192.39 Million | Rs184.75 Million | Rs164.49 Million | Rs70.64 Million | Rs61.73 Million |
| Change in Cash | Rs-12.47 Million | Rs11.88 Million | Rs115.64 Million | Rs776.00K | Rs-6.02 Million |
Borosil Scientific Earnings History — EPS Actual vs. Analyst Estimates
Track Borosil Scientific's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
Earnings history is not currently available for Borosil Scientific.